LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that effective immediately, Bryan McMillan has been promoted to President of the Spine Global Business Unit. Mr. McMillan had been serving as the Executive Vice President-General Manager for the Spinal Implants division of the Global Business Unit since February 2011. Mr. McMillan has been with the Company since March 2010 in various roles of increasing responsibilities, including Vice President of Global Development for Spinal Implants and Executive Vice President-General Manager for Spinal Implants. Mr. McMillan will be responsible for overseeing all activities of the Company’s Spinal Implants and Spinal Stimulation businesses, which were previously managed separately.
“I am certain that as President of the Spine Global Business Unit, he can further drive growth while creating synergies and cross-selling opportunities between our best in class spinal implants, biologics, and our market leading spinal stimulation products.”
“Bryan has proven himself as an exceptional leader in our Spinal Implants business,” said Robert Vaters, the Company’s President and Chief Executive Officer. “I am certain that as President of the Spine Global Business Unit, he can further drive growth while creating synergies and cross-selling opportunities between our best in class spinal implants, biologics, and our market leading spinal stimulation products.”
Orthofix International N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical products for the spine, orthopedics, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages helping them achieve a more active and mobile lifestyle. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, including BREG, Inc., and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, Texas Scottish Rite Hospital for Children, and the Cleveland Clinical Foundation. For more information about Orthofix, please visit www.orthofix.com.
Orthofix International N.V.
Brian McCollum, 214-937-2927
Chief Financial Officer
Recent Stories from Orthofix International N.V.